电邮这篇文章 Transport Platform Synthesis for Drug Development
- 作者: Stukalov Y.V.1, Grigor’eva E.Y.1, Kulakov V.N.2, Baryshnikov A.Y.1
-
隶属关系:
- N. N. Blokhin Russian Cancer Research Center
- A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
- 期: 卷 51, 编号 6 (2017)
- 页面: 480-481
- 栏目: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/244661
- DOI: https://doi.org/10.1007/s11094-017-1637-9
- ID: 244661
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
Asynthetic scheme for a transport platform for the creation of new diagnostic and therapeutic antitumor drugs that was based on a dendrimer with a core of pentaerythritol tetraglycidyl ether (TGEPE) and dendra with diallylamine was developed. The transport platform was promising for designing targeted antitumor agents for magnetic resonance tomography and nuclear medicine.
作者简介
Yu. Stukalov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
俄罗斯联邦, 24 Kashirskoe Shosse, Moscow, 115478
E. Grigor’eva
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
俄罗斯联邦, 24 Kashirskoe Shosse, Moscow, 115478
V. Kulakov
A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
Email: chem@folium.ru
俄罗斯联邦, 46 Zhivopisnaya St, Moscow, 123182
A. Baryshnikov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
俄罗斯联邦, 24 Kashirskoe Shosse, Moscow, 115478
补充文件
